Portfolio company
EditForce
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech firm develops RNA editing tools and therapies for pharmaceutical, industrial, and agricultural organisations to treat diseases and manipulate genes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rewrite Therapeutics
This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.
SymphoRNA
This deep-tech company develops multi-RNA combination medicines to treat complex diseases such as fibrosis and heart failure for the pharmaceutical and healthcare sectors.
ParcelBio
This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.
Kodikaz Therapeutic Solutions
This deep-tech company develops a non-viral delivery platform for cell-specific gene therapies to treat cancer patients.
Granza Bio
This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.
GenEdit
This deep-tech firm develops polymer nanoparticle delivery systems for genetic medicines to treat autoimmune diseases for the pharmaceutical and biotechnology industries.
Helix Nanotechnologies
This deep-tech company develops an mRNA platform to create vaccines and therapies for biotechnology organisations and patients with complex immune requirements.
Komo Biosciences
This deep-tech firm provides precision genome engineering technology and cell lines to therapeutic developers, biologics manufacturers, and agricultural biotechnology companies.
